跳至主要内容
临床试验/ACTRN12621000721808
ACTRN12621000721808招募中未知

Effect of Vasopressor Infusion via Peripheral vs Central Access on 60 day survival in patients with shock - (The VIPCA trial)

Caboolture Hospital0 个研究点目标入组 40 人开始时间: 2021年6月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • * Patients admitted to Caboolture Hospital ED
  • * Any unplanned admission to Caboolture Hospital ICU
  • * greater than 18 years
  • * Treating clinician has deemed that a Vasopressor Infusion is required

排除标准

  • * Pregnancy or suspected pregnancy
  • * Treating clinician believes that survival beyond 48 hours is unlikely or patient being admitted to ICU solely for Palliation or Organ Donation
  • * Has received vasopressor infusion for 4 hours
  • * Requiring >0.1mcg/kg/min noradrenaline (or equivalent dose of other vasopressors) at the time of screening; or requiring >1 vasopressor agent
  • * Patient already has a CVC in-situ or requires a CVC insertion for specific therapies other than vasopressors (e.g., total parenteral nutrition, severe electrolyte derangements like: K+ less than or equal to 2.0 mmol/L, PO4-2 less than or equal to 0.3 mmol/L, or for Ca+2 infusion for CRRT)

研究者

发起方
Caboolture Hospital

相似试验

Vasopressor Infusion via Peripheral vs Central... | 临床试验